Duration of SARS‐CoV‐2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID‐19
Abstract To investigate the factors associated with the duration of severe acute respiratory syndrome coronavirus 2 RNA shedding in patients with coronavirus disease 2019 (COVID‐19). A retrospective cohort of COVID‐19 patients admitted to a designated hospital in Beijing was analyzed to study the factors affecting the duration of viral shedding. The median duration of viral shedding was 11 days (IQR, 8‐14.3 days) as measured from illness onset. Univariate regression analysis showed that disease severity, corticosteroid therapy, fever (temperature>38.5°C), and time from onset to hospitalization were associated with prolonged duration of viral shedding ( P < .05). Multivariate regression analysis showed that fever (temperature>38.5°C) (OR, 5.1, 95%CI: 1.5‐18.1), corticosteroid therapy (OR, 6.3, 95%CI: 1.5‐27.8), and time from onset to hospitalization (OR, 1.8, 95%CI: 1.19‐2.7) were associated with increased odds of prolonged duration of viral shedding. Corticosteroid treatment, fever (temperature>38.5°C), and longer time from onset to hospitalization were associated with prolonged viral shedding in COVID‐19 patients..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:93 |
|---|---|
| Enthalten in: |
Journal of Medical Virology - 93(2021), 1, Seite 506-512 |
| Beteiligte Personen: |
Li, Tong‐Zeng [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2020 Wiley Periodicals LLC |
|---|
| Umfang: |
7 |
|---|
| doi: |
10.1002/jmv.26280 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY008989036 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY008989036 | ||
| 003 | DE-627 | ||
| 005 | 20230307183027.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230217s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/jmv.26280 |2 doi | |
| 028 | 5 | 2 | |a JMV_JMV26280.xml |
| 035 | |a (DE-627)WLY008989036 | ||
| 035 | |a (WILEY)JMV26280 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.43 |2 bkl | ||
| 100 | 1 | |a Li, Tong‐Zeng |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Duration of SARS‐CoV‐2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID‐19 |
| 264 | 1 | |c 2021 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2020 Wiley Periodicals LLC | ||
| 520 | |a Abstract To investigate the factors associated with the duration of severe acute respiratory syndrome coronavirus 2 RNA shedding in patients with coronavirus disease 2019 (COVID‐19). A retrospective cohort of COVID‐19 patients admitted to a designated hospital in Beijing was analyzed to study the factors affecting the duration of viral shedding. The median duration of viral shedding was 11 days (IQR, 8‐14.3 days) as measured from illness onset. Univariate regression analysis showed that disease severity, corticosteroid therapy, fever (temperature>38.5°C), and time from onset to hospitalization were associated with prolonged duration of viral shedding ( P < .05). Multivariate regression analysis showed that fever (temperature>38.5°C) (OR, 5.1, 95%CI: 1.5‐18.1), corticosteroid therapy (OR, 6.3, 95%CI: 1.5‐27.8), and time from onset to hospitalization (OR, 1.8, 95%CI: 1.19‐2.7) were associated with increased odds of prolonged duration of viral shedding. Corticosteroid treatment, fever (temperature>38.5°C), and longer time from onset to hospitalization were associated with prolonged viral shedding in COVID‐19 patients. | ||
| 700 | 1 | |a Cao, Zhen‐Huan |4 aut | |
| 700 | 1 | |a Chen, Yu |4 aut | |
| 700 | 1 | |a Cai, Miao‐Tian |4 aut | |
| 700 | 1 | |a Zhang, Long‐Yu |4 aut | |
| 700 | 1 | |a Xu, Hui |4 aut | |
| 700 | 1 | |a Zhang, Jia‐Ying |4 aut | |
| 700 | 1 | |a Ma, Chun‐Hua |4 aut | |
| 700 | 1 | |a Liu, Yang |4 aut | |
| 700 | 1 | |a Gao, Li‐Juan |4 aut | |
| 700 | 1 | |a Duan, Zhong‐Hui |4 aut | |
| 700 | 1 | |a Mou, Dan‐Lei |4 aut | |
| 700 | 1 | |a Liang, Lian‐Chun |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Medical Virology |g 93(2021), 1, Seite 506-512 |w (DE-627)WLY008980918 |x 10969071 |7 nnns |
| 773 | 1 | 8 | |g volume:93 |g year:2021 |g number:1 |g pages:506-512 |g extent:7 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 936 | b | k | |a 44.43 |q ASE |
| 951 | |a AR | ||
| 952 | |d 93 |j 2021 |e 1 |h 506-512 |g 7 | ||